104th Annual Meeting of the South Central Section of the American Urological Association (AUA)
SCS AUA 2025 Prostate Cancer
- SCS AUA 2025: Is There a Role for an Intraoperative Steep Trendelenburg Break During Robot-Assisted Laparoscopic Radical Prostatectomies? Results from an Academic Training Program
- SCS AUA 2025: Low Serum Testosterone Level and Biopsy Grade Group Progression Among Men with Prostate Cancer on Active Surveillance
- SCS AUA 2025: Incidental Prostate Lesions on FDG PET/CT and Prostate Cancer Risk: A Single-Center Retrospective Study
- SCS AUA 2025: Biparametric MRI for Prostate Cancer Detection: A Cost-Effective Approach in Latin America
- SCS AUA 2025: SUVmax Overexpression in PSMA PET/CT Determines Aggressiveness According to ISUP Score in Prostate Cancer: A Multicenter Study Based on the Mexican Population
SCS AUA 2025 Bladder Cancer
- SCS AUA 2025: Underreporting of CIS in Patients with High-Grade Papillary NMIBC
- SCS AUA 2025: Novel Therapeutic Regimens in Previously Untreated Metastatic Urothelial Carcinoma: A Systematic Review and Bayesian Network Meta-Analysis
- SCS AUA 2025: Trial in Progress: PIVOT-006 – a Phase 3, Randomized Study of Adjuvant Intravesical Cretostimogene Grenadenorepvec Versus Surveillance for the Treatment of Intermediate Risk NMIBC
- SCS AUA 2025: Penelope: Tissue Penetration of Gemcitabine Phosphate Metabolites Following TAR-200 Administration Versus Standard Intravesical Instillation in Minipigs
- SCS AUA 2025: Streamlined, Patient-Centric Design of the Cretostimogene Grenadenorepvec Expanded Access Program in Patients with NMIBC Unresponsive to BCG
SCS AUA 2025 Kidney Cancer
- SCS AUA 2025: Efficacy and Safety of Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Combination Regimen in Metastatic RCC
- SCS AUA 2025: Contemporary Outcomes for Radical Nephrectomy with Inferior Vena Cava Thrombectomy in the Era of Pre-Operative Immunotherapy
- SCS AUA 2025: Pre-Clinic Educational Information’s Effect on Anxiety in Patients with Renal Masses
- SCS AUA 2025: Improving the Identification of Predictive Risk Factors to Refine the Indication of Adjuvant Therapy in Intermediate Localized and Locally Advanced RCC Patients
- SCS AUA 2025: Cytoreductive Nephrectomy after Immune Checkpoint Inhibitor Therapy in Metastatic RCC
SCS AUA 2025 Upper Tract Urothelial Carcinoma
- SCS AUA 2025: Long-Term Outcomes of Adjuvant UGN-101 in a Real-World Cohort
- SCS AUA 2025: Oncologic Outcomes of Kidney-Sparing Surgery with or Without Adjuvant UGN-101 in Upper Tract Urothelial Carcinoma: A Single Institution Series
- SCS AUA 2025: Oncological and Surgical Outcomes of Endoscopic Therapy Compared to Surgical Resection of Upper Tract Urothelial Carcinoma Stratified by Tumor Grade: Analysis of National Cancer Database